HIV-related health complications and treatmentsHIV Research and TreatmentHIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsImmune Cell Function and Interaction
Publications
71
Citations
2,427
Est. group size
—
Recurring co-author estimate
Active years
38
Publishing since 1988
Publication cadence
Publications per year over the last 10 years — averaging 3.4/year recently
Recent publications
- Canadian guideline on HIV pre- and postexposure prophylaxis: 2025 update
Canadian Medical Association Journal · 2025
- Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy–Treated Individuals With Undetectable Viremia
The Journal of Infectious Diseases · 2023
- The Frequency and Function of NKG2C+CD57+ Adaptive NK Cells in Cytomagalovirus Co-Infected People Living with HIV Decline with Duration of Antiretroviral Therapy
Viruses · 2023
- CD4/CD8 Ratio Outcome According to the Class of the Third Active Drug in Antiretroviral Therapy Regimens: Results From the Quebec Human Immunodeficiency Virus Cohort Study
Clinical Infectious Diseases · 2023
- Epicardial fat density, coronary artery disease and inflammation in people living with HIV
Medicine · 2023
- Plasmatic HIV-1 soluble gp120 is associated with immune dysfunction and inflammation in ART-treated individuals with undetectable viremia
medRxiv · 2023
- Population-level effectiveness of pre-exposure prophylaxis for HIV prevention among men who have sex with men in Montréal: a modelling study of surveillance and survey data
medRxiv · 2023
- Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIV
Frontiers in Cardiovascular Medicine · 2022
- Association Between the Development of Subclinical Cardiovascular Disease and Human Immunodeficiency Virus (HIV) Reservoir Markers in People With HIV on Suppressive Antiretroviral Therapy
Clinical Infectious Diseases · 2022
- Long-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of Study
Open Forum Infectious Diseases · 2022
- Opt-out universal HCV and HIV screening in a Canadian emergency room: a cross-sectional study
BMJ Open · 2022
- Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)
Patient Preference and Adherence · 2022
- High frequencies of adaptive NK cells are associated with absence of coronary plaque in cytomegalovirus infected people living with HIV
Medicine · 2022
- Cross-sectional comparison of age- and gender-related comorbidities in people living with HIV in Canada
Medicine · 2022
- Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis
Frontiers in Immunology · 2021
Publishes in
- Medicine×4
- Journal of Virus Eradication×4
- Clinical Infectious Diseases×3
- AIDS×3
- Open Forum Infectious Diseases×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile